HCC occurrence was significantly inhibited after treatment with clodronate liposome (Figure 5K), and further investigation found that treatment of clodronate liposome significantly decreased the expression of ID1 in HPCs (Figure 5M). This evidence concerns the gene ID1 and hepatocellular carcinoma.